NorthSea Therapeutics B.V
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From NorthSea Therapeutics B.V
Private Company Edition: Omega Funds closed its seventh venture capital fund, far exceeding its $500m goal. Also, Anaveon raised a CHF110m ($119.8m) series B round, Ambys brought its series A total to $107m with $47m in additional investment and Mythic launched with a $103m series B round.
Immersive technologies are becoming a reality in the OR. In Vivo explores the future of surgery, profiling innovators of augmented reality technologies and exploring the promise and challenges surrounding robotic surgery as companies try to take technologies to the next level.
Digital Health Roundup, May 2021: Immersive Technologies In Surgery Suite, ‘Smart’ Toilets And Pills; New SaMD Cybersecurity Standards
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from May.
Medtronic teamed up with Surgical Theater to integrate its SyncAR technology with its StealthStation S8 surgical navigation platform to help neurosurgeons navigate complex brain surgeries.
- Large Molecule